4//SEC Filing
Conway Charles 4
Accession 0001562180-22-000355
CIK 0001689813other
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 9:18 PM ET
Size
17.5 KB
Accession
0001562180-22-000355
Insider Transaction Report
Form 4
Conway Charles
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Shares
2022-01-06+3,750→ 23,935 total - Tax Payment
Common Shares
2022-01-06$123.86/sh−1,800$222,948→ 22,135 total - Exercise/Conversion
Restricted Share Unit Award
2022-01-06−3,750→ 7,500 total→ Common Shares (3,750 underlying) - Award
Employee Stock Option (right to buy)
2022-01-07+23,000→ 23,000 totalExercise: $128.87Exp: 2032-01-07→ Common Shares (23,000 underlying) - Award
Restricted Share Unit Award
2022-01-07+11,500→ 11,500 total→ Common Shares (11,500 underlying)
Footnotes (7)
- [F1]This balance includes 288 shares that were acquired through the Biohaven Employee Share Purchase Plan on May 31, 2021.
- [F2]No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units.
- [F3]Each restricted share unit represents the contingent right to receive one common share of the Issuer.
- [F4]The reporting person was granted 15,000 restricted share units on January 6, 2021, vesting in four equal installments on January 6, 2021, 2022, 2023 and 2024, subject to the reporting person's continued service with the Issuer at each vesting date.
- [F5]Not applicable.
- [F6]The shares underlying this option vest in four equal installments on January 7, 2022, 2023, 2024 and 2025, subject to the reporting person's continuous service with the Issuer at each vesting date.
- [F7]The reporting person was granted 11,500 restricted share units on January 7, 2022, vesting in four equal installments on January 7, 2022, 2023, 2024 and 2025, subject to the reporting person's continued service with the Issuer at each vesting date. 100% of these restricted share units are generally subject to settlement in 10 equal annual installments after separation from service.
Issuer
Biohaven Pharmaceutical Holding Co Ltd.
CIK 0001689813
Entity typeother
Related Parties
1- filerCIK 0001704256
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 9:18 PM ET
- Size
- 17.5 KB